Stocks and Investing Stocks and Investing
Fri, February 25, 2022
[ 12:00 AM ] - United States, WOPRAI
James Thalacker Maintained (AEP) at Buy with Decreased Target to $94 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Dana Telsey Maintained (BURL) at Buy with Decreased Target to $300 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Shyam Patil Maintained (BKNG) at Buy on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Brian Gong Maintained (ATHM) at Hold with Decreased Target to $30 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ryan Koontz Maintained (BAND) at Strong Buy with Decreased Target to $45 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Alicia Yap Maintained (BABA) at Strong Buy with Decreased Target to $200 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Scott Devitt Maintained (BABA) at Strong Buy with Decreased Target to $135 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Eddie Leung Maintained (BABA) at Strong Buy with Decreased Target to $193 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Jerry Liu Maintained (BABA) at Strong Buy with Decreased Target to $150 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Gary Yu Maintained (BABA) at Buy with Decreased Target to $145 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Scott Berg Maintained (AXON) at Strong Buy with Decreased Target to $170 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Paul Chung Upgraded (AXON) to Buy and Decreased Target to $192 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
David Lewis Maintained (AXNX) at Buy with Decreased Target to $69 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Danielle Antalffy Maintained (AXNX) at Buy with Increased Target to $65 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
John Baumgartner Maintained (BYND) at Hold with Decreased Target to $45 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Lavery Maintained (BYND) at Hold with Decreased Target to $50 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Ken Goldman Maintained (BYND) at Sell with Decreased Target to $32 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Bobby Burleson Maintained (BYND) at Hold with Decreased Target to $50 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Chris Pierce Maintained (CARG) at Strong Buy with Increased Target to $52 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Adam Tindle Maintained (ALRM) at Strong Buy with Decreased Target to $85 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Curt Woodworth Maintained (AMBP) at Buy with Decreased Target to $12 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matt Borsch Upgraded (AMED) to Buy and Held Target at $190 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
Michael Wiederhorn Maintained (AMED) at Buy with Decreased Target to $200 on, Feb 25th, 2022
[ 12:00 AM ] - United States, WOPRAI
A.J. Rice Maintained (AMED) at Buy with Decreased Target to $195 on, Feb 25th, 2022
Thu, February 24, 2022
[ 12:00 AM ] - United States, WOPRAI
Bill Sutherland Maintained (AMED) at Strong Buy with Decreased Target to $175 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Mayank Tandon Maintained (ALKT) at Strong Buy with Decreased Target to $22 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Andrew Berens Maintained (AZN) at Buy with Increased Target to $70 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Alex Yao Maintained (BABA) at Buy and Held Target at $180 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
James Fish Maintained (BAND) at Buy with Decreased Target to $51 on, Feb 24th, 2022
[ 12:00 AM ] - United States, WOPRAI
Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $41 on, Feb 24th, 2022

Matthew Mishan Maintained (AVNS) at Buy with Decreased Target to $41 on, Feb 24th, 2022


Published on 2024-10-27 19:49:52 - WOPRAI, Matthew Mishan
  Print publication without navigation


Matthew Mishan of Keybanc, Maintained "Avanos Medical, Inc." (AVNS) at Buy with Decreased Target from $47 to $41 on, Feb 24th, 2022.

Matthew has made no other calls on AVNS in the last 4 months.



There is 1 other peer that has a rating on AVNS. Out of the 1 peers that are also analyzing AVNS, 0 agree with Matthew's Rating of Hold.



This is the rating of the analyst that currently disagrees with Matthew

  • Drew Ranieri of "Morgan Stanley" Maintained at Sell with Decreased Target to $36 on, Friday, January 7th, 2022

Contributing Sources